Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin D Berger

Showing results (31-40 of 111) with videos related to

Pageof 12
Sort By:
Oncoimmunology|May 17, 2017
Digital analysis and epigenetic regulation of the signature of rejection in colorectal cancerViktor H Koelzer, Lena Sokol, Stefan Zahnd, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 9, 2025
MSAI-Path: Predicting Microsatellite Instability From Routine Histology Slides Without Reinventing the WheelElias Baumann, Luca E M Schäfer, Frédérique Meeuwsen, et al.
NPJ Precision Oncology|June 13, 2025
Deep learning-based quantification of eosinophils and lymphocytes shows complementary prognostic effects in colorectal cancer patientsElias Baumann, Sophie Lechner, Philippe Krebs, et al.
Thyroid : Official Journal of the American Thyroid Association|October 16, 2018
Histology of Nivolumab-Induced ThyroiditisChristina Neppl, Reto M Kaderli, Roman Trepp, et al.
Leukemia Research|April 20, 2015
CD34+ selected versus unselected autologous stem cell transplantation in patients with advanced-stage mantle cell and diffuse large B-cell lymphomaMartin D Berger, Giacomo Branger, Kurt Leibundgut, et al.
Leukemia Research|December 16, 2016
Consolidation with autologous stem cell transplantation in first remission is safe and effective in AML patients above 65 yearsAlexander D Heini, Martin D Berger, Katja Seipel, et al.
BMC Cancer|September 16, 2022
A combined spatial score of granzyme B and CD68 surpasses CD8 as an independent prognostic factor in TNM stage II colorectal cancerLuca Noti, José A Galván, Heather Dawson, et al.
Cancer Treatment Reviews|December 15, 2018
B cell and B cell-related pathways for novel cancer treatmentsRyuma Tokunaga, Madiha Naseem, Jae Ho Lo, et al.
Clinical Colorectal Cancer|November 4, 2018
Stromal PD-1/PD-L1 Expression Predicts Outcome in Colon Cancer PatientsJacqueline Wyss, Bastian Dislich, Viktor H Koelzer, et al.
Journal of Cancer Metastasis and Treatment|September 17, 2021
Pharmacogenomics in colorectal cancer: current role in clinical practice and future perspectivesFrancesca Battaglin, Alberto Puccini, Madiha Naseem, et al.
Pageof 12

Showing results (31-40 of 111) with videos related to

Sort By:
Pageof 12
Oncoimmunology|May 17, 2017
Digital analysis and epigenetic regulation of the signature of rejection in colorectal cancerViktor H Koelzer, Lena Sokol, Stefan Zahnd, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 9, 2025
MSAI-Path: Predicting Microsatellite Instability From Routine Histology Slides Without Reinventing the WheelElias Baumann, Luca E M Schäfer, Frédérique Meeuwsen, et al.
NPJ Precision Oncology|June 13, 2025
Deep learning-based quantification of eosinophils and lymphocytes shows complementary prognostic effects in colorectal cancer patientsElias Baumann, Sophie Lechner, Philippe Krebs, et al.
Thyroid : Official Journal of the American Thyroid Association|October 16, 2018
Histology of Nivolumab-Induced ThyroiditisChristina Neppl, Reto M Kaderli, Roman Trepp, et al.
Leukemia Research|April 20, 2015
CD34+ selected versus unselected autologous stem cell transplantation in patients with advanced-stage mantle cell and diffuse large B-cell lymphomaMartin D Berger, Giacomo Branger, Kurt Leibundgut, et al.
Leukemia Research|December 16, 2016
Consolidation with autologous stem cell transplantation in first remission is safe and effective in AML patients above 65 yearsAlexander D Heini, Martin D Berger, Katja Seipel, et al.
BMC Cancer|September 16, 2022
A combined spatial score of granzyme B and CD68 surpasses CD8 as an independent prognostic factor in TNM stage II colorectal cancerLuca Noti, José A Galván, Heather Dawson, et al.
Cancer Treatment Reviews|December 15, 2018
B cell and B cell-related pathways for novel cancer treatmentsRyuma Tokunaga, Madiha Naseem, Jae Ho Lo, et al.
Clinical Colorectal Cancer|November 4, 2018
Stromal PD-1/PD-L1 Expression Predicts Outcome in Colon Cancer PatientsJacqueline Wyss, Bastian Dislich, Viktor H Koelzer, et al.
Journal of Cancer Metastasis and Treatment|September 17, 2021
Pharmacogenomics in colorectal cancer: current role in clinical practice and future perspectivesFrancesca Battaglin, Alberto Puccini, Madiha Naseem, et al.
Pageof 12